Prioritizing Cultural Relevance and Co-Production in Cardiovascular Technologies: A Call for Action

Saleema Allana1, Ibukun Abejirinde, Emily Seto

  • 1Saleema Allana, PhD, RN, ELHA, Assistant Professor, School of Nursing, Western University, London, Ontario, Canada. Ibukun Abejirinde, MD, MSc, PhD, Assistant Professor, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Emily Seto, MSc, PhD, Associate Professor, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Quynh Pham, MSc, PhD, Assistant Professor, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Enid Montague, MSc, PhD, Professor, Industrial Engineering, University of Toronto,Toronto, Canada. Monica Parry, MEd, MSc, NP-Adult, PhD, CCN(C), FAAN, FCAN, FAHA, FPCNA, Professor, Lawrence Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada. Bukola Salami, RN, PhD, FCAN, FAAN, Full Professor, Faculty of Nursing, Cumming School of Medicine, University of Calgary, Calgary, Canada. Tanvir Chowdhury Turin, MBBS, MS, PhD, Associate Professor, Department of Family Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Jamaul Taylor, MPH (In Progress), Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Ridah Asghar, BA, Director of Development, Council of Agencies Serving South Asians, Toronto, Canada. Gavin Oudit, MD, PhD, FRCPC, FCAHS; Professor, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta Clinician-Scientist, Toronto, Canada. Akm Alamgir, PhD, Director, Organizational Learning and Knowledge, Access Alliance, Edmonton, Canada. Simone Cowan, MD, Division of Cardiology & Cardiac Surgery, University of British Columbia, Toronto, Canada. Shahin Jaffer, MD, MHSc, FRCPC, Clinical Professor, Division of Community General Internal Medicine, University of British Columbia, Vancouver, Canada.

Summary

No abstract available in PubMed .

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...